ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
67.011,78
-0,10%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Newellis Inc (NUWE)

  7. Newellis Inc (NUWE) News

NUWE

Newellis (NUWE)

Newellis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:NUWE
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202423h22Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:NUWENewellis Inc
17/05/202423h20Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:NUWENewellis Inc
14/05/202415h00GlobeNewswire Inc.Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in FloridaNASDAQ:NUWENewellis Inc
09/05/202415h00GlobeNewswire Inc.Nuwellis Announces Purchase Agreement with a 50 Hospital Network for Aquadex Ultrafiltration TherapyNASDAQ:NUWENewellis Inc
08/05/202423h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NUWENewellis Inc
08/05/202423h26Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:NUWENewellis Inc
07/05/202414h00GlobeNewswire Inc.Nuwellis, Inc. Announces First Quarter 2024 Financial ResultsNASDAQ:NUWENewellis Inc
02/05/202415h00GlobeNewswire Inc.Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT TechnologyNASDAQ:NUWENewellis Inc
01/05/202400h09GlobeNewswire Inc.Nuwellis Announces Closing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
30/04/202422h41GlobeNewswire Inc.Nuwellis, Inc. To Report First Quarter 2024 Financial Results on May 7, 2024NASDAQ:NUWENewellis Inc
26/04/202415h17GlobeNewswire Inc.Nuwellis Announces Pricing of $2.7 Million Public OfferingNASDAQ:NUWENewellis Inc
09/04/202415h00GlobeNewswire Inc.Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford HealthNASDAQ:NUWENewellis Inc
11/03/202422h08Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NUWENewellis Inc
07/03/202415h08GlobeNewswire Inc.Late-Breaking Data Highlighting Benefits of Ultrafiltration Therapy Using the Aquadex System for Heart Failure Patients was Presented at the Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
06/03/202418h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
05/03/202414h00GlobeNewswire Inc.Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:NUWENewellis Inc
05/03/202412h05IH Market NewsU.S. Futures Dip, Crude Oil FluctuatesNASDAQ:NUWENewellis Inc
27/02/202415h00GlobeNewswire Inc.Nuwellis, Inc. To Report Fourth Quarter and Full Year 2023 Financial Results on March 5, 2024NASDAQ:NUWENewellis Inc
22/02/202413h58GlobeNewswire Inc.Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™NASDAQ:NUWENewellis Inc
20/02/202423h06GlobeNewswire Inc.Nuwellis, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NUWENewellis Inc
20/02/202414h42GlobeNewswire Inc.Nuwellis to Announce Late-Breaking Clinical Data and Host Satellite Symposium at Technology and Heart Failure Therapeutics ConferenceNASDAQ:NUWENewellis Inc
08/02/202423h19Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:NUWENewellis Inc
06/02/202415h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
06/02/202415h00GlobeNewswire Inc.New Case Series Demonstrates Potential of Aquadex Therapy for End-Stage Liver Disease Patients with Fluid OverloadNASDAQ:NUWENewellis Inc
09/01/202423h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NUWENewellis Inc
08/01/202415h24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
04/01/202422h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NUWENewellis Inc
04/01/202421h05GlobeNewswire Inc.Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral CatheterNASDAQ:NUWENewellis Inc
13/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NUWENewellis Inc
28/11/202314h00GlobeNewswire Inc.New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric PatientsNASDAQ:NUWENewellis Inc
 Showing the most relevant articles for your search:NASDAQ:NUWE

Kürzlich von Ihnen besucht

COIN
PRMUSD
BIT
UB8HRV
Unicredit Bank
TG
PSAN
PSI Software
BIT
S28960
Societe Generale Effekten
BOV
A1PA34Q
Apache
NASDAQ
ABBFFXX
Morgan Stanley Finance L...
EU
H939T
H939T
BIT
F07207
Vontobel Financial Produ...
NASDAQ
PAFOU
Pacifico Acquisition
BIT
SBAD5L
SG Issuer Societe Generale
EU
EZ70
Euronext Eurozone 70 EW ...
NASDAQ
ARILX
Aristotle Core Equity Fu...
BIT
UV4KYG
UniCredit Bank
EU
DSD
Lyxor Asset Management
USOTC
RNVA
Rennova Health (PK)
BOV
ABEV3R
AMBEV S/A ON
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten